GlassScriptPhysician profile
Kourtnee Lindgren
NPI 1942629738
$677.22
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $32.12 · 2021: $349 · 2022: $70.62.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $275.37 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.46 | 2019-2020 | |
| Abbvie INC. | $52.92 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $46.11 | 2019 | |
| Exeltis, USA INC. | $43.21 | 2021-2022 | |
| Hologic Sales and Service, LLC | $34.74 | 2019 | |
| Lupin INC. | $29.86 | 2019-2020 | |
| Myovant Sciences INC. | $26.89 | 2022 | |
| Allergan, INC. | $24.44 | 2019 | |
| Evofem Biosciences, INC. | $20.56 | 2022 | |
| Minerva Surgical, INC | $20.44 | 2019 | |
| Merck Sharp & Dohme LLC | $18.53 | 2019 | |
| Avion Pharmaceuticals | $16.49 | 2021 | |
| Therapeuticsmd, INC. | $14.20 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kourtnee Lindgren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.